Loomis Sayles & CO L P Eli Lilly & CO Transaction History

Loomis Sayles & CO L P

$72.6 Billion
Q2 2024

A detailed history of Loomis Sayles & CO L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,499 shares of LLY stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,499

Previous 1,268 18.22%

Holding current value

$1.32 Million

Previous $986,000 37.63%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $167,444 - $209,988	231 Added 18.22%	1,499 $1.36 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $143,904 - $192,524	243 Added 23.71%	1,268 $986,000
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $23,108 - $27,241	-44 Reduced 4.12%	1,025 $597,000
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $355,149 - $489,628	817 Added 324.21%	1,069 $574,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $5,261 - $7,034	-15 Reduced 5.62%	252 $118,000
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $45,662 - $53,628	147 Added 122.5%	267 $92,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $10,611 - $12,364	33 Added 37.93%	120 $44,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $592 - $675	-2 Reduced 2.25%	87 $28,000
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $1,114 - $1,309	-4 Reduced 4.3%	89 $29,000
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $13,612 - $16,916	-58 Reduced 38.41%	93 $27,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $13,940 - $17,300	-62 Reduced 29.11%	151 $42,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $9,750 - $11,999	44 Added 26.04%	213 $49,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1,083 - $1,401	6 Added 3.68%	169 $39,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $1.47 Million - $1.91 Million	-8,962 Reduced 98.21%	163 $30,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $286,359 - $378,922	2,195 Added 31.67%	9,125 $1.54 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $25,296 - $29,259	-173 Reduced 2.44%	6,930 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $116,093 - $139,717	-851 Reduced 10.7%	7,103 $1.17 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $382,983 - $474,024	3,217 Added 67.91%	7,954 $1.1 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $696,476 - $862,649	-6,514 Reduced 57.9%	4,737 $623,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $1.2 Million - $1.31 Million	11,251 New	11,251 $1.26 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $3.11 Million - $3.66 Million	-27,971 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $8.52 Million - $9.54 Million	-80,434 Reduced 74.2%	27,971 $3.24 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $19.2 Million - $24 Million	-223,943 Reduced 67.38%	108,405 $11.6 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $9.51 Million - $10.9 Million	-125,590 Reduced 27.43%	332,348 $28.4 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $387,895 - $457,885	-5,227 Reduced 1.13%	457,938 $35.4 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $6.43 Million - $6.9 Million	-78,508 Reduced 14.49%	463,165 $39.1 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $1.19 Million - $1.32 Million	-15,421 Reduced 2.77%	541,673 $46.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	557,094	557,094 $45.8 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Eli Lilly & CO Transaction History